These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 25572531

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
    Gronier B.
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374
    [Abstract] [Full Text] [Related]

  • 3. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.
    Gamo NJ, Wang M, Arnsten AF.
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1011-23. PubMed ID: 20855046
    [Abstract] [Full Text] [Related]

  • 4. Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex.
    Chen L, Yang CR.
    J Neurophysiol; 2002 May; 87(5):2324-36. PubMed ID: 11976371
    [Abstract] [Full Text] [Related]

  • 5. The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex.
    Gronier B, Waters S, Ponten H.
    J Neural Transm (Vienna); 2013 Sep; 120(9):1281-94. PubMed ID: 23468085
    [Abstract] [Full Text] [Related]

  • 6. Methylphenidate exerts dose-dependent effects on glutamate receptors and behaviors.
    Cheng J, Xiong Z, Duffney LJ, Wei J, Liu A, Liu S, Chen GJ, Yan Z.
    Biol Psychiatry; 2014 Dec 15; 76(12):953-62. PubMed ID: 24832867
    [Abstract] [Full Text] [Related]

  • 7. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms.
    Tseng KY, O'Donnell P.
    J Neurosci; 2004 Jun 02; 24(22):5131-9. PubMed ID: 15175382
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.
    Sarantis K, Matsokis N, Angelatou F.
    Neuroscience; 2009 Nov 10; 163(4):1135-45. PubMed ID: 19647050
    [Abstract] [Full Text] [Related]

  • 10. Methylphenidate amplifies long-term potentiation in rat hippocampus CA1 area involving the insertion of AMPA receptors by activation of β-adrenergic and D1/D5 receptors.
    Rozas C, Carvallo C, Contreras D, Carreño M, Ugarte G, Delgado R, Zeise ML, Morales B.
    Neuropharmacology; 2015 Dec 10; 99():15-27. PubMed ID: 26165920
    [Abstract] [Full Text] [Related]

  • 11. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.
    Lecourtier L, Homayoun H, Tamagnan G, Moghaddam B.
    Biol Psychiatry; 2007 Oct 01; 62(7):739-46. PubMed ID: 17511968
    [Abstract] [Full Text] [Related]

  • 12. Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine.
    Shi WX, Zhang XX.
    J Pharmacol Exp Ther; 2003 May 01; 305(2):680-7. PubMed ID: 12606677
    [Abstract] [Full Text] [Related]

  • 13. cAMP and extracellular signal-regulated kinase signaling in response to d-amphetamine and methylphenidate in the prefrontal cortex in vivo: role of beta 1-adrenoceptors.
    Pascoli V, Valjent E, Corbillé AG, Corvol JC, Tassin JP, Girault JA, Hervé D.
    Mol Pharmacol; 2005 Aug 01; 68(2):421-9. PubMed ID: 15890841
    [Abstract] [Full Text] [Related]

  • 14. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ, Muhlhauser M, Zhai J, Yang CR, Nisenbaum ES.
    J Pharmacol Exp Ther; 2001 Jul 01; 298(1):86-102. PubMed ID: 11408529
    [Abstract] [Full Text] [Related]

  • 15. Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.
    Zhang CL, Feng ZJ, Liu Y, Ji XH, Peng JY, Zhang XH, Zhen XC, Li BM.
    PLoS One; 2012 Jul 01; 7(12):e51910. PubMed ID: 23284812
    [Abstract] [Full Text] [Related]

  • 16. Disrupted Glutamatergic Transmission in Prefrontal Cortex Contributes to Behavioral Abnormality in an Animal Model of ADHD.
    Cheng J, Liu A, Shi MY, Yan Z.
    Neuropsychopharmacology; 2017 Sep 01; 42(10):2096-2104. PubMed ID: 28176786
    [Abstract] [Full Text] [Related]

  • 17. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
    Arvanov VL, Wang RY.
    Neuropsychopharmacology; 1998 Mar 01; 18(3):197-209. PubMed ID: 9471117
    [Abstract] [Full Text] [Related]

  • 18. Methylphenidate significantly alters the functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area.
    Dela Peña IC, Shen G, Shi WX.
    Neuropharmacology; 2018 Mar 15; 131():431-439. PubMed ID: 29339293
    [Abstract] [Full Text] [Related]

  • 19. Treatment with a clinically-relevant dose of methylphenidate alters NMDA receptor composition and synaptic plasticity in the juvenile rat prefrontal cortex.
    Urban KR, Li YC, Gao WJ.
    Neurobiol Learn Mem; 2013 Mar 15; 101():65-74. PubMed ID: 23333502
    [Abstract] [Full Text] [Related]

  • 20. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
    Bradshaw SE, Agster KL, Waterhouse BD, McGaughy JA.
    Brain Res; 2016 Jun 15; 1641(Pt B):245-57. PubMed ID: 26774596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.